Phase II study of vinorelbine (Navelbine) in previously treated small cell lung cancer patients
- 1 January 1993
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 29 (12) , 1720-1722
- https://doi.org/10.1016/0959-8049(93)90112-s
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- A Phase II Study of Navelbine (Vinorelbine) in the Treatment of Non-Small-Cell Lung CancerAmerican Journal of Clinical Oncology, 1991
- Second line chemotherapy in small cell lung cancerLung Cancer, 1989
- Good clinical practice: a way to better drugs.BMJ, 1989
- Teniposide in the treatment of small-cell lung cancer: the influence of prior chemotherapy.Journal of Clinical Oncology, 1988
- Retreatment with the induction regimen in small cell lung cancer relapsing after an initial response to short term chemotherapyEuropean Journal of Cancer and Clinical Oncology, 1987
- Teniposide (VM-26), an overlooked highly active agent in small-cell lung cancer. Results of a phase II trial in untreated patients.Journal of Clinical Oncology, 1986
- Phase I pharmacologic study of a new Vinca alkaloid: NavelbineCancer Letters, 1985
- Reporting results of cancer treatmentCancer, 1981
- ChemInform Abstract: A NEW CLASS OF ANTITUMOR COMPOUNDS: 5′-NOR AND 5′,6′-SECO DERIVATIVES OF VINBLASTINE-TYPE ALKALOIDSChemischer Informationsdienst, 1980
- A new class of antitumor compounds: 5'-nor and 5',6'-seco derivatives of vinblastine-type alkaloidsThe Journal of Organic Chemistry, 1979